Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D-gluconhydroximo-1,5-lactam is a small molecule belonging to the class of organic compounds known as tetrahydropyridines. It has the chemical formula C6H12N2O5 and a molecular weight of 192.17 g/mol[1][5][6]. The compound has been studied primarily in experimental settings and is not approved for clinical use. Research indicates that D-gluconhydroximo-1,5-lactam and its derivatives have been evaluated for their ability to inhibit certain enzymes and act as pharmacological chaperones[7]. One identified biological target is lactase/phlorizin hydrolase (LCT), an intestinal brush border enzyme responsible for hydrolyzing lactose into glucose and galactose[1]. However, the precise mechanism of action in humans remains unclear.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on d-gluconhydroximo-1,5-lactam.